RxDoctor Payments Data

Jeffrey Davis, DPM

Primary Podiatric Medicine · Concord, NHNPI 1336190198

Payments from drug & device makers

$14,382in general payments, 2019–2025

Across 12 payments — averaging $1198.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$14K
  • Stryker$88
  • Wishbone Medical Inc.$31
  • Mimedx Group, Inc.$25
  • Pfizer$16

What the payments were for

  • Food & beverage$160100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few primary podiatric medicine providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$190,575
Medicare patients
742
Services billed
2,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate18$200
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$108
Cephalexin13$55

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Concord

Where these figures come from

Is this you, or does something look wrong? →